BioNexus Gene Lab Corp. Payments of Financing Costs
BioNexus Gene Lab Corp. (BGLC) reported Payments of Financing Costs of $3.33 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2022-05-16
- BioNexus Gene Lab Corp. payments of financing costs for the quarter ending 2022-03-31 was $3.33K, a 0.95% decline year-over-year.
- BioNexus Gene Lab Corp. payments of financing costs for the quarter ending 2021-09-30 was $2.15K, a 8.74% decline year-over-year.
- BioNexus Gene Lab Corp. payments of financing costs for the quarter ending 2021-06-30 was $3.45K, a 149.86% increase year-over-year.
- BioNexus Gene Lab Corp. payments of financing costs for the quarter ending 2021-03-31 was $3.36K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 3 month as first filed | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month |
|---|---|---|---|---|
| 2022-03-31 | $3.33K 10-Q · filed 2022-05-16 | |||
| 2021-09-30 | $2.15K 10-Q · filed 2021-11-15 | $5.60K derived: sum of 2 quarters · filed 2021-11-15 | $8.99K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.45K 10-Q · filed 2021-08-12 | $6.84K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $3.36K 10-Q · filed 2022-05-16 | -$3.36K 10-Q · filed 2021-05-18 | ||
| 2020-09-30 | $2.36K 10-Q · filed 2021-11-15 | $3.74K derived: sum of 2 quarters · filed 2021-11-15 | $6.76K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $1.38K 10-Q · filed 2021-08-12 | $4.41K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$3.03K 10-Q · filed 2021-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |